Thursday, March 30, 2017 12:06:14 PM
mCig 3FQ17 10-Q
The 10-Q does not contain any quarter to consecutive quarter comparison. They compare this quarter this year (Omni Health financials) to this quarter last year (VitaCig financials). To get an apples to apples comparison, they give us a pro forma summary which shows Omni's results this 3FY compared to Omni's results last year's 3FQ...
It shows a small increase of about $130k in costs for the quarter compared to last year (primarily from consulting expenses having to do with going public) but a decrease of $640k in expenses through the first nine months of the year.
Totally false! Here's the relevant section from the 10-Q...
It shows that a number of loans were taken out in the spring and summer of 2016 to assist in the process of going public. These loans originally totaled $2,256,987 and have been gradually paid off to where on 1/31/17 they totalled only $1,446,528. That's a decrease of $810,459 in less than a year. The loan payments are included in the expenses discussed above.
Again, look at the pro forma financials above, they show an operating profit of $593,858 through the first three quarters of FY17 and a net income of $1,531,480.
Total BS with no basis in fact. It's contradicted by the fact that last quarter, the shares outstanding (OS) went from 1,148,328,741 on 10/31/16 to 975,828,741 on 1/31/17. LX Retail Group and Omni currently own more shares than are required to maintain 50% controlling interest. They can use those for an acquisition, convert them along with the rest of their common shares to convertible preferreds, or retire them. They have plenty of options to further reduce OS. There's never anything keeping any company from raising cash with a stock offering if that's what they want to do. It's a true statement about every single stock company.
A totally ridiculous statement. mCig's business plan involves Construction and Consulting (Grow Contractors), CBD Sales, Inhalation Technology (VitaCig and Vapolution), and they recently added Cannabis Supply. Omni's business plan was revealed in their PR...
Omni Health, Inc. Issues Letter to Shareholders
Just add these to your long list of Debunked Claims.
Les
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM